Dr. Tatiana Borer

Dr. Tatiana Borer, MD, MBA, currently serves as Vice President Launch Lead International and VP, Head of Hematology at Sobi - Swedish Orphan Biovitrum AB, where responsibilities include leading the global asset launch of Doptelet and Pegcetacoplan. Prior experience includes pivotal roles at Takeda Pharmaceuticals, focusing on portfolio strategy and launch preparation, particularly in hematology and CNS, as well as a robust background at Nycomed in strategic marketing for biological products across various therapeutic areas. Dr. Borer holds an MD in Neurology from The Russian State Medical University and an MBA in Marketing from Moscow International Higher Business School MIRBIS.